Faculty
Oncology Division
Alphabetical list (active faculty):   
Neha Mehta-Shah

Neha Mehta-Shah, MD, MSCI

Associate Professor

Department of Medicine

Oncology Division

Medical Oncology

Clinical Interests

  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • T/NK-cell lymphomas
  • Cutaneous lymphoma

Contact

  • 314-454-8313 (office)
  • 314-747-5123 (fax)
  • Division of Oncology
    Mail Stop 8056-0029-11
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid Campus Center (office)

Peer-reviewed Publications

  • Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing
    Akkad N, Kodgule R, Duncavage EJ, Mehta-Shah N, Spencer DH, Watkins M, Shirai C, Myckatyn T
    Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print]
  • Management of Peripheral T-Cell Lymphomas and the Role of Transplant
    Foley NC, Mehta-Shah N
    Curr Oncol Rep 2022 Nov;24(11):1489-1499
  • EXABS-185-TCL the Next Rational Therapeutic Regimen in Newly Diagnosed PTCL
    Mehta-Shah N
    Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86
  • TCL-495 Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing
    Akkad N, Kodgule R, Duncavage E, Mehta-Shah N, Watkins M, Shirai C, Myckatyn T
    Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402
  • ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study
    Flowers C, Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Salles G
    Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359
  • An Updated Approach and Understanding of Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Mehta-Shah N, Ghione P
    J Natl Compr Canc Netw 2022 Mar;20(3):309-315
  • T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H
    J Natl Compr Canc Netw 2022 Mar;20(3):285-308
  • COVID-19 Booster Vaccines Generate Seroconversion in Subset of Patients With Lymphoma/CLL: Single Institution Experience
    Mehta-Shah N, Bartlett NL, Kahl B, Watkins MP, Dubois A, Schmelzle G, Waqar S, Ballman C, Wan F, Farnsworth CW
    Leuk Lymphoma 2022 Jul;63(7):1723-1727
  • Improving Eligibility Criteria for First-Line Trials for Patients With DLBCL Using a US-Based Delphi-Method Survey
    Harkins RA, Patel SP, Lee MJ, Switchenko JM, Ansell SM, Bartlett NL, Blum KA, Cashen AF, Casulo C, Friedberg JW, Johnston PB, Kahl BS, Leonard JP, Link BK, Lossos IS, Martin P, Maurer MJ, Mehta-Shah N, Reagan PM, Westin JR, Koff JL, Flowers CR
    Blood Adv 2022 May 10;6(9):2745-2756
  • Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Flowers CR, Salles G
    N Engl J Med 2022 Jan 27;386(4):351-363
  • Metabolic Biomarkers Assessed With PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients With Diffuse Large B-Cell Lymphoma
    Jaswal S, Sanders V, Pullarkat P, Teja S, Salter A, Watkins MP, Atagu N, Ludwig DR, Mhlanga J, Mellnick VM, Peterson LR, Bartlett NL, Kahl BS, Fehniger TA, Ghobadi A, Cashen AF, Mehta-Shah N*, Ippolito JE* (*co-senior author)
    Cancers (Basel) 2022 Jun 14;14(12):2932
  • Scarring Alopecia Developing After Mogamulizumab-Associated Rash
    Raval NS, Snowden CK, De Monnin KS, Yokoyama CC, Choi J, Mehta-Shah N, Rosman IS, Pavlisin J, Musiek AC
    Eur J Dermatol 2021 Dec 1;31(6):841-843
  • Alopecia Areata After Mogamulizumab Treatment
    Raval NS, Alexander NA, De Monnin K, Yokoyama CC, Mehta-Shah N, Rosman IS, Musiek AC
    JAAD Case Rep 2021 Nov 18;19:68-70
  • An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Harrop S, Mehta-Shah N, Dsouza C, Thompson E, Deva A, Prince HM
    Cancers (Basel) 2021 Sep 30;13(19):13194921
  • Phase I Trial of N-803, an IL15 Receptor Agonist, With Rituximab in Patients With Indolent Non-Hodgkin Lymphoma
    Foltz JA, Hess BT, Bachanova V, Bartlett NL, Berrien-Elliott MM, McClain E, Becker-Hapak M, Foster M, Schappe T, Kahl B, Mehta-Shah N, Cashen AF, Marin ND, McDaniels K, Moreno C, Mosior M, Gao F, Griffith OL, Griffith M, Wagner JA, Epperla N, Rock AD, Lee J, Petti AA, Soon-Shiong P, Fehniger TA
    Clin Cancer Res 2021 Jun 15;27(12):3339-3350
  • Romidepsin and Lenalidomide-Based Regimens Have Efficacy in Relapsed/Refractory Lymphoma: Combined Analysis of Two Phase I Studies With Expansion Cohorts
    Mehta-Shah N, Lunning MA, Moskowitz AJ, Boruchov AM, Ruan J, Lynch P, Hamlin PA, Leonard J, Matasar MJ, Myskowski PL, Marzouk E, Nair S, Sholklapper T, Minnal V, Palomba ML, Vredenburgh J, Kumar A, Noy A, Straus DJ, Zelenetz AD, Schoder H, Rademaker J, Schaffer W, Galasso N, Ganesan N, Horwitz SM
    Am J Hematol 2021 Oct 1;96(10):1211-1222
  • Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides
    Walker CJ, Espinosa ML, Mehta-Shah N, Pro B, Guitart J, Kuzel T
    J Drugs Dermatol 2021 Mar 1;20(3):349-350
  • Current Measures Are Not Sufficient: An Interview-Based Qualitative Assessment of Quality of Life in Cutaneous T-Cell Lymphoma
    Bhat TS, Herbosa CM, Rosenberg AR, Sogade O, Jeffe DB, Mehta-Shah N, Semenov YR, Musiek AC
    Br J Dermatol 2021 Feb;184(2):310-318
  • CAR-Modified Memory-Like NK Cells Exhibit Potent Responses to NK-Resistant Lymphomas
    Gang M, Marin ND, Wong P, Neal CC, Marsala L, Foster M, Schappe T, Meng W, Tran J, Schaettler M, Davila M, Gao F, Cashen AF, Bartlett NL, Mehta-Shah N, Kahl BS, Kim MY, Cooper ML, DiPersio JF, Berrien-Elliott MM, Fehniger TA
    Blood 2020 Nov 12;136(20):2308-2318
  • NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
    Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H
    J Natl Compr Canc Netw 2020 Nov 2;18(11):1460-1467
  • T Follicular Helper Phenotype Predicts Response to Histone Deacetylase Inhibitors in Relapsed/Refractory Peripheral T-Cell Lymphoma
    Ghione P, Faruque P, Mehta-Shah N, Seshan V, Ozkaya N, Bhaskar S, Yeung J, Spinner MA, Lunning M, Inghirami G, Moskowitz A, Galasso N, Ganesan N, van der Weyden C, Ruan J, Prince HM, Trotman J, Advani R, Dogan A, Horwitz S
    Blood Adv 2020 Oct 13;4(19):4640-4647
  • Lenalidomide Demonstrates Clinical Activity in Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma
    Bhaskar S, Abro B, Fraum TJ, Mehta-Shah N
    BMJ Case Rep 2020 Aug 25;13(8)
  • NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
    Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH
    J Natl Compr Canc Netw 2020 May;18(5):522-536
  • Rituximab/Bendamustine and Rituximab/Cytarabine Induction Therapy for Transplant-Eligible Mantle Cell Lymphoma
    Merryman RW, Edwin N, Redd R, Bsat J, Chase M, LaCasce A, Freedman A, Jacobson C, Fisher D, Ng S, Crombie J, Kim A, Odejide O, Davids MS, Brown JR, Jacene H, Cashen A, Bartlett NL, Mehta-Shah N, Ghobadi A, Kahl B, Joyce R, Armand P, Jacobsen E
    Blood Adv 2020 Mar 10;4(5):858-867
  • Clinical Severity Measures and Quality-Of-Life Burden in Patients With Mycosis Fungoides and Sezary Syndrome: Comparison of Generic and Dermatology-Specific Instruments
    Herbosa CM, Semenov YR, Rosenberg AR, Mehta-Shah N, Musiek AC
    J Eur Acad Dermatol Venereol 2020 May;34(5):995-1003
  • A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    Ghosh T, Duncavage E, Mehta-Shah N, McGuire PA, Tenenbaum M, Myckatyn TM
    Aesthet Surg J 2020 Nov 19;40(12):1288-1300
  • Health-Related Quality of Life and Economic Implications of Cutaneous T-Cell Lymphoma
    Semenov YR, Rosenberg AR, Herbosa C, Mehta-Shah N, Musiek AC
    Br J Dermatol 2020 Jan;182(1):190-196
  • Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study
    Zinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Manley T, Francis S, Sharma M, Moskowitz AJ
    J Clin Oncol 2019 Nov 20;37(33):3081-3089
  • Novel Cell Adhesion/Migration Pathways Are Predictive Markers of HDAC Inhibitor Resistance in Cutaneous T Cell Lymphoma
    Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE
    EBioMedicine 2019 Aug;46:170-183
  • Multicenter Analysis of Outcomes in Blastic Plasmacytoid Dendritic Cell Neoplasm Offers a Pretargeted Therapy Benchmark
    Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A Jr, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA
    Blood 2019 Aug 22;134(8):678-687
  • Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
    Chen L, Carson KR, Staser KW, Mehta-Shah N, Schaffer A, Rosman IS, Musiek A
    JAMA Dermatol 2019;155(8):968-971
  • Baseline and Interim Functional Imaging With PET Effectively Risk Stratifies Patients With Peripheral T-Cell Lymphoma
    Mehta-Shah N, Ito K, Bantilan K, Moskowitz AJ, Sauter C, Horwitz SM, Schoder H
    Blood Adv 2019 Jan 22;3(2):187-197
  • The Genetic Basis of Hepatosplenic T-Cell Lymphoma
    McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Dave SS
    Cancer Discov 2017 Apr;7(4):369-379
  • Lenalidomide in Adult T-Cell Leukemia/Lymphoma
    Mehta-Shah N, Horwitz SM
    J Clin Oncol 2016 Dec;34(34):4066-4067
  • Central Nervous System Involvement in T-Cell Lymphoma: A Single Center Experience
    Gurion R, Mehta N, Migliacci JC, Zelenetz A, Moskowitz A, Lunning M, Moskowitz C, Hamlin P, Horwitz S
    Acta Oncol 2016 May;55(5):561-6
  • Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
    Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN
    J Clin Oncol 2016 Jan 10;34(2):160-8
  • Novel Targeted Therapies in Diffuse Large B-Cell Lymphoma
    Mehta-Shah N, Younes A
    Semin Hematol 2015 Apr;52(2):126-37
  • Adnexal Mass Secondary to Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) With Associated Amyloid Deposition
    Mehta N, Schoder H, Chiu A, Schoolmeester JK, Portlock C
    BMJ Case Rep 2014 Nov 14;2014 pii: bcr2014206699
  • A Retrospective Analysis of Peripheral T-Cell Lymphoma Treated With the Intention to Transplant in the First Remission
    Mehta N, Maragulia JC, Moskowitz A, Hamlin PA, Lunning MA, Moskowitz CH, Zelenetz A, Matasar MJ, Sauter C, Goldberg J, Horwitz SM
    Clin Lymphoma Myeloma Leuk 2013 Dec;13(6):664-70
  • Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
    Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S
    Clin Lymphoma Myeloma Leuk 2012 Feb;12(1):20-5
  • Alemtuzumab for Relapsed and Refractory Erythrodermic Cutaneous T-Cell Lymphoma: A Single Institution Experience From the Robert H. Lurie Comprehensive Cancer Center
    Querfeld C, Mehta N, Rosen ST, Guitart J, Rademaker A, Gerami P, Kuzel TM
    Leuk Lymphoma 2009 Dec;50(12):1969-76

Invited Publications

Book Chapters

  • Lymphomas
    Mehta-Shah N
    In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology Review, 5th Edition (Morgensztern D, Govindan R, Devarakonda S, Trikalinos NA, Editors), Wolters Kluwer, Philadelphia, 2022
  • Non-Hodgkin Lymphoma
    Kahl BS, Mehta-Shah N
    In: The Washington Manual of Oncology, 4th Edition (Morgensztern D, Ghobadi A, Govindan R, Editors), Wolters Kluwer, Philadelphia, 2022
  • Hodgkin Lymphoma
    Malecek MK, Mehta-Shah N
    In: The Washington Manual of Oncology, 4th Edition (Morgensztern D, Ghobadi A, Govindan R, Editors), Wolters Kluwer, Philadelphia, 2022
  • Non-Hodgkin’s Lymphoma
    Kahl BS, Mehta-Shah N
    In: The Washington Manual of Oncology, 4th Edition (Govindan R, Morgensztern D, eds.), Wolters Kluwer, Philidelphia, PA, 2021
  • Mature T-Cell and NK-Cell Lymphomas
    Mehta-Shah N, Moskowitz A, Horwitz SM
    In: Williams Hematology, 9th Edition (Kaushansky K, Lichtman M, Prchal J, Levi M, Burns L, Linch DC, eds.), McGraw-Hill Education/Medical, 2021
  • Adult T-Cell Leukemia/Lymphoma
    Lunning M, Mehta-Shah N, Horwitz S
    In: Abeloff's Clinical Oncology, 6th Edition (Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds.), Elsevier, Philadelphia, PA, 2020
  • Enteropathy-Associated T-Cell Lymphomas
    Teja S, Mehta-Shah N
    In: Novel Therapeutics for Rare Lymphomas (Dittus C, ed.), Springer Nature Switzerland AG, Cham, Switzerland, 2020
  • T-Cell Lymphomas
    Mehta N, Younes A
    In: Handbook of Lymphoma (Younes A, ed.), Springer, New York, NY, 2016
  • Mature T-Cell and NK-Cell Lymphomas
    Mehta N, Moskowitz A, Horwitz SM
    In: Williams Hematology, 9th Edition (Kaushansky, Lichtman, Prchal, Levi, Press, Burns, Caligiuri, eds.), McGraw Hill, Burr Ridge, IL, 2015
  • Cancer and Nephrotic Syndrome
    Mehta N, Niesvizky R
    In: Encyclopedia of Medical Immunology (Mackay IR, Rose NR, eds.), Springer, New York, NY, 2014
  • Transfusion in Medicine
    Mehta N, Wuest D
    In: Pocket Oncology (Drillon A, Krug L, Postow M, eds.), Lippincott Williams & Wilkins, Philadelphia, PA, 2014